Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement: the complexity of the elderly.

导出 OA

翻译打印收藏纠错

作者： Leonardo,Bencivenga ^[1] ; Immacolata,Sepe ^[2] ; Maria Emiliana,Palaia ^[1] ; Klara,Komici ^[1] ; Graziamaria,Corbi ^[3] ; Brunella,Puzone ^[3] ; Michele,Arcopinto ^[1] ; Antonio,Cittadini ^[1] ; Nicola,Ferrara ^[1] ; Grazia Daniela,Femminella ^[1] ; Giuseppe,Rengo ^[4]

作者单位： Department of Translational Medical Sciences, University of Naples "Federico II", Via Sergio Pansini 5, Naples 80131, Italy. ^[1] Department of Advanced Biomedical Sciences, University of Naples "Federico II", Via Sergio Pansini 5, Naples 80131, Italy. ^[2] Department of Medicine and Health Sciences, University of Molise, Via Francesco De Sanctis 1, Campobasso 86100, Italy. ^[3] Istituti Clinici Scientifici Maugeri SPA, Società Benefit, IRCCS, Istituto Scientifico di Telese, Via Bagni Vecchi 1, Telese Terme 82037 (BN), Italy. ^[4] Department of Medicine, Imperial College London, South Kensington Campus, London SW7 2AZ, UK. ^[5]

关键词 Antithrombotic therapy Aortic stenosis Atrial fibrillation Autonomic dysfunction COVID-19 Chronic kidney disease Elderly Geriatric syndromes TAVR

主题词年龄因素(Age Factors);老年人(Aged);主动脉瓣狭窄(Aortic Valve Stenosis);纤维蛋白溶解药(Fibrinolytic Agents);人类(Humans);危险因素(Risk Factors)

DOI 10.1093/eurjpc/zwaa053

PMID 33624104

发布时间 2023-11-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交